Description of the blood test:

Anti-SS-B antibodies, also known as Anti-La, target a 48kDa phosphoprotein that is involved in the processing of RNA within the cell. These antibodies are almost always found in association with Anti-SS-A (Ro) antibodies. Their primary clinical significance lies in diagnosing Sjögren’s Syndrome and providing additional evidence for Systemic Lupus Erythematosus (SLE). It is rare to find Anti-La without Anti-Ro, but when both are present, the diagnosis of Sjögren’s is significantly more likely.

What Does the Test Represent?

• Goal: To detect and measure IgG antibodies against the SS-B (La) antigen.
• Main Application: Confirming Sjögren’s Syndrome, especially when SS-A results are borderline, and assessing risks of neonatal lupus.
• Method: ELISA or Immunoblot.

Collection Recommendations (General)

• Timing: Morning collection is standard.
• Fasting: Fasting for 8–12 hours is recommended; plain water is allowed.
• Material: Venous blood (serum).
• Specific Rules: This test is usually part of a broader ENA (Extractable Nuclear Antigen) panel.

Factors Influencing the Result

• Sensitivity and Specificity: Anti-SS-B is less common than Anti-SS-A but is considered more specific for Primary Sjögren’s Syndrome. It is found in about 40–60% of cases.
• The “Ro-Negative” Exception: While very uncommon, testing positive for La but negative for Ro can sometimes occur, though it often warrants a re-test or a more detailed antibody profile.
• Relationship to SLE: In Lupus patients, the presence of Anti-La often correlates with a lower risk of severe kidney disease compared to those with Anti-dsDNA.

When to Take This Test?

• Recommendations: If you have severe “Sicca” symptoms (dryness of the mouth, eyes, and skin); if you have already tested positive for Anti-SS-A (Ro); or if a newborn has a skin rash or heart rhythm issues after birth from an autoimmune mother.
• Importance: Finding both Ro and La antibodies provides a strong diagnostic foundation for Sjögren’s, allowing the doctor to focus on protecting the mucosal surfaces (eyes, mouth, vagina) from chronic inflammation.

Medical Interpretation

• Crucial Note: Like many autoimmune markers, these antibodies can exist for years before severe symptoms appear. Only a specialist can “fine-tune” the treatment by evaluating if the dryness is causing functional damage, such as corneal ulcers or dental decay.
• Positive Result: Highly suggestive of Sjögren’s Syndrome or SLE.
• Negative Result: Does not rule out Sjögren’s, as a significant portion of patients (up to 50%) do not produce Anti-La.

Possible Further Investigations

• Anti-SS-A (Ro) Antibodies: The most important test to compare against.
• Salivary Flow Rate Test: To objectively measure how much saliva the glands are producing.
• Ophthalmological Exam: Including a Rose Bengal or Fluorescein stain to check for dry spots on the eye.
• C3 and C4 Complement: To check for systemic immune activity.
• Consultation with a Rheumatologist.

When Does the Next Step Make Sense?

• If the Anti-SS-B test is positive, the next step is usually to manage the symptoms of dryness and screen for systemic involvement (such as joint pain or lung inflammation). For pregnant women, the presence of Anti-La (especially with Anti-Ro) necessitates specialized fetal heart monitoring to prevent congenital heart block.
• All clinical decisions must be made by a healthcare professional based on the total antibody profile and clinical presentation.

👉 If necessary, you can discuss the analysis results with a specialist such as a rheumatologist (Doctors – TAMC).